HIZENTRA®


 
 
 
 
 
 
 
 
 


 

HIZENTRA® is a subcutaneous immune globulin used to treat Chronic Inflammatory Demyelinating Polyneuropathy and Primary Immunodeficiency.

HIZENTRA® is manufactured by CSL Behring.

Administration and Dosage:

Administration of HIZENTRA® is dependent on the patient’s IgG levels at start of therapy.

Common Side Effects:

The more common side effects of HIZENTRA® include thrombosis, kidney problems, blood clots, meningitis, brown or red urine, rapid heart rate, yellowing of the skin or eyes, chest pains or breathing trouble, and fever over 100°F.

More Information:

Please read the full Prescribing Information for HIZENTRA® and discuss any questions you have with your doctor.

Ready to Schedule an Appointment?

Please CLICK HERE to get started.

Indication:

HIZENTRA® is indicated to treat:

  • Chronic Inflammatory Demyelinating Polyneuropathy
  • Primary Immunodeficiency